TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease
Top Cited Papers
- 1 August 2001
- Vol. 15 (2), 289-302
- https://doi.org/10.1016/s1074-7613(01)00183-2
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseasesArthritis & Rheumatism, 2001
- Lymphocyte Survival--Ignorance Is BLysScience, 2000
- Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell PopulationThe Journal of Experimental Medicine, 2000
- B‐cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”Immunological Reviews, 2000
- Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responsesEuropean Journal of Immunology, 1997
- Aberrant B Cell Development and Immune Response in Mice with a Compromised BCR ComplexScience, 1996
- Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase SykNature, 1995
- Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression.The Journal of Experimental Medicine, 1994
- Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.The Journal of Experimental Medicine, 1993
- The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.The Journal of Experimental Medicine, 1991